ATE164163T1 - Dialkyl (dialkoxyphosphinyl)methyl phosphate als antientzündungsmittel - Google Patents

Dialkyl (dialkoxyphosphinyl)methyl phosphate als antientzündungsmittel

Info

Publication number
ATE164163T1
ATE164163T1 AT92913025T AT92913025T ATE164163T1 AT E164163 T1 ATE164163 T1 AT E164163T1 AT 92913025 T AT92913025 T AT 92913025T AT 92913025 T AT92913025 T AT 92913025T AT E164163 T1 ATE164163 T1 AT E164163T1
Authority
AT
Austria
Prior art keywords
dialkoxyphosphinyl
diethoxyphosphinyl
dialkyl
phosphonic acid
diethyl ester
Prior art date
Application number
AT92913025T
Other languages
English (en)
Inventor
Roy Allen Johnson
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE164163T1 publication Critical patent/ATE164163T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657181Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • C07F9/5728Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analyzing Materials By The Use Of Fluid Adsorption Or Reactions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92913025T 1991-06-19 1992-05-21 Dialkyl (dialkoxyphosphinyl)methyl phosphate als antientzündungsmittel ATE164163T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71742891A 1991-06-19 1991-06-19

Publications (1)

Publication Number Publication Date
ATE164163T1 true ATE164163T1 (de) 1998-04-15

Family

ID=24881993

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92913025T ATE164163T1 (de) 1991-06-19 1992-05-21 Dialkyl (dialkoxyphosphinyl)methyl phosphate als antientzündungsmittel

Country Status (10)

Country Link
US (1) US5347029A (de)
EP (1) EP0590009B1 (de)
JP (1) JPH06508365A (de)
AT (1) ATE164163T1 (de)
AU (1) AU657554B2 (de)
CA (1) CA2102303A1 (de)
DE (1) DE69224830D1 (de)
MX (1) MX9202997A (de)
TW (1) TW201751B (de)
WO (1) WO1992022559A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681798A (en) * 1996-08-01 1997-10-28 Farng; Liehpao O. Load-carrying additives based on organo-phosphites and amine phosphates
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
WO2004108736A1 (ja) * 2003-06-09 2004-12-16 Daihachi Chemical Industry Co., Ltd. ホスフェート-ホスホネート結合を有する有機リン化合物、およびそれを用いた難燃性ポリエステル繊維、難燃性ポリウレタン樹脂組成物
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
EP2282735B1 (de) 2008-04-21 2019-01-16 Signum Biosciences, Inc. Pp2a modulatoren zur behandlung von alzheimer, parkinson, diabetes
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
US8445002B2 (en) 2009-05-06 2013-05-21 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
EP2493905B1 (de) 2009-10-26 2016-11-30 Warner Chilcott Company, LLC Bisphosphonatverbindungen zur behandlung von gestörtem knochenmetabolismus
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
ES2686880T3 (es) * 2016-03-31 2018-10-22 Ivoclar Vivadent Ag Monómeros híbridos ácidos y materiales dentales basados en los mismos

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB207285A (en) * 1922-09-06 1923-11-29 Herbert Cowburn Improvements in artificial flowers
US3808237A (en) * 1970-04-13 1974-04-30 Monsanto Co Substituted epoxy ethane polyphosphonic acids and salts
GB2043072B (en) * 1979-02-13 1983-11-23 Symphar Sa Diphosphonate compounds
FR2531088B1 (fr) * 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3643684A1 (de) * 1986-12-20 1988-06-30 Hoechst Ag Verfahren zur herstellung von halogenierten phosphono-phosphorsaeureestern und ihre verwendung
US5190930A (en) * 1987-12-11 1993-03-02 Ciba-Geigy Corporation Araliphatylaminoalkanediphosphonic acids
CA1339805C (en) * 1988-01-20 1998-04-07 Yasuo Isomura (cycloalkylamino)methylenebis(phosphonic acid) and medicines containing the same as an active
JPH0377894A (ja) * 1989-08-18 1991-04-03 Toray Ind Inc メチレンジホスホン酸化合物
ATE133677T1 (de) * 1990-12-19 1996-02-15 Takeda Chemical Industries Ltd Bisphosphonsäurederivate, ihre produktion und ihre verwendung
US5254544A (en) * 1992-09-25 1993-10-19 E. R. Squibb & Sons, Inc. Hydroxyphosphinyl phosphonate squalene synthetase inhibitors and method

Also Published As

Publication number Publication date
AU2029292A (en) 1993-01-12
DE69224830D1 (en) 1998-04-23
US5347029A (en) 1994-09-13
AU657554B2 (en) 1995-03-16
EP0590009A1 (de) 1994-04-06
MX9202997A (es) 1993-02-01
JPH06508365A (ja) 1994-09-22
WO1992022559A1 (en) 1992-12-23
EP0590009B1 (de) 1998-03-18
TW201751B (de) 1993-03-11
CA2102303A1 (en) 1992-12-20

Similar Documents

Publication Publication Date Title
ATE164163T1 (de) Dialkyl (dialkoxyphosphinyl)methyl phosphate als antientzündungsmittel
Yavari et al. One-pot stereoselective synthesis of dimethy (2-hydroxy-4, 4-dimethylcyclohex-1-en-6-one-1-yl)-3-(diphenylphosphonato) butanedioate
EP0094687B1 (de) Phosphinylalkanoyl substituierte Iminosäuren
KR900001711A (ko) 디포스폰산 유도체, 이들을 제조하는 방법 및 이들 화합물을 함유하는 제약조성물
ATE120753T1 (de) Bisphosphonsäurederivate als antiarthritische mittel.
US5536863A (en) (Pentaerythritol phosphate alcohol) (cyclic neopentylene glycol) phosphite and phosphonate
NO933885L (no) gsmåte
IE842268L (en) Process for preparation of nucleoside alkyl-,aralkyl- and¹aryl phosphonites and phosphonates
DK0816368T3 (da) Kemisk phosphorylering af oligonukleotider og reaktanter anvendt dertil
PT771813E (pt) Fosfonatos de alquilxantina e fosfinoxidos de alquilxantina e sua utilizacao como medicamentos
US2923730A (en) Dithiophosphoric acid esters and their preparation
IL81154A (en) Orally active antihypertensive(s)-1-(6-amino-2-((hydroxy(4-phenylbutyl)phosphinyl)oxy)-1-oxohexyl)-l-proline and salts thereof
US3183258A (en) Dialkyl 1-acylamino 2, 2-dichlorovinyl phosphates
FI883207A (fi) Foerfarande foer framstaellning av aminometylenfosfonoalkylfosfinater.
Nizamov et al. Tetraphosphorus trisulfide in reactions with thioacetals, aminals, sulfenamides and disulfides. Influence of amines and benzoyl peroxide
Blackburn et al. The synthesis of O, O-bistrimethylsilyl S-trihalogenomethyl phosphorothioates
Hudson et al. ORGANOPHOSPHORUS COMPOUNDS AS POTENTIAL FUNGICIDES. PART V. 1 THE PREPARATION AND PROPERTIES OF SOME NOVEL N, N, N', N'-TETRAMETHYL-N''-(1-SUBSTITUTED-2, 2, 2-TRICHLOROETHYL) PHOSPHORIC TRIAMIDES
DE3411282A1 (de) Phoshonamid-substituierte lactame
FI822201A0 (fi) Mono- och diestrar av n-alkylsubstituerad aminometylfosfonsyra och foerfarande foer deras framstaellning
Gratchev et al. The Synthesis and Structure of P (Iii)-Phosphorylated 2-Aminopyrrolines
ATE649T1 (de) 2-cyclopropyl-pyrimidin(4 )yl-(thiono)(thiol)-phosp hor-(phosphon)-saeureester, verfahren zu ihrer herstellung und ihre verwendung als insektizide und akarizide.
Dai et al. A Facile Synthesis of 1-Benzyloxycarbonylamino-(substituted) phenylmethylphosphinates
Muller et al. A MECHANISTIC STUDY OF THE REACTION OF PHOSPHONITE ESTERS WITH ETHYL AND METHYL N-CHLOROACETIMIDE1
HUBER III PART I: ATTEMPTED SYNTHESIS OF VINYL (PHOSPHONYLMETHYL) PHOSPHINIC ACID DERIVATIVES. PART II: SYNTHESIS OF ND-ALANYL-1-AMINOETHYLPHOSPHONIC ACID.
Eccles The synthesis and fungicidal activity of some novel phosphoramidates

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties